Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02983604
Title GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Women's Cancer Center Stanford California 94305 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Allina Health, Virginia Piper Cancer Institute Minneapolis Minnesota 55407 United States Details
The Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Baylor University Medical Center Houston Texas 77030 United States Details
Medical Oncology Associates, PS (dba Summit Cancer Centers) Spokane Washington 99208 United States Details
*Shaded cells indicate that there was no data available from for the field